Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 23, Issue 8, 1996, Pages 1332-1337

  Hoa, Tran Thi Minh ^a   Hasunuma, Tomoko ^a   Aono, Hiroyuki ^a   Masuko, Kayo ^a   Kobata, Tetsuji ^a   Yamamoto, Kazuhiko ^b   Sumida, Takayuki ^a   Nishioka, Kusuki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Fas antigen; Fas ligand; Rheumatoid arthritis; T cells

Indexed keywords

FAS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; T LYMPHOCYTE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; BASE SEQUENCE; BLOTTING, SOUTHERN; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0029774592     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Harris ED Jr: Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Stamenkovic I, Stegagno M, Wright KA, et al: Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci USA 1988;85:1179-83.
3. Iwakura Y, Tosu M, Yoshida E, et al: Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991;253:1026-8.
4. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Nerenberg M: Human T-call leukemia virus type I tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. Science 1992;258:1792-5.
5. Nakajima T, Aono H, Hasunuma T, et al: Overgrowth of human synovial cells driven by the human T cells leukemia virus type 1 tax gene. J Clin Invest 1993;92:186-93.
6. Yamamoto K, Sakoda H, Nakajima T, et al: Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int Immunol 1992;4:1219-23.
7. Itoh N, Yonehara S, Ishii A, et al: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
8. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;15:1169-78.
9. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature 1992;356:314-7.
10. Takahashi T, Tanaka M, Brannan CI, et al: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994;76:969-76.
11. Rieux-Lancat F, Le Deist F, Hivroz C, et al: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268:1347-9.
12. Fisher GH, Rosenberg FJ, Straus SE, et al: Dominant interfering Fas gene mutation impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-46.
13. Nakajima T, Aono H, Hasunuma T, et al: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:484-91.
14. Arnett FC, Edworthy M, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Kinoshita T, Imamura J, Nagai H, Shimotohno K: Quantification of gene expression over a wide range by the polymerase chain reaction. Anal Biochem 1992;206:231-5.
16. Lanzillo JJ: Chemiluminescent nucleic acid detection with digoxigenin-labeled probes: A model system with probes for angiotensin converting enzyme which detect less than one attomole of target DNA. Anal Biochem 1991;194:45-53.
17. Miyawaki T, Uehara T, Nibu R, et al: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992;149:3753-8.
18. Trauth BC, Klas C, Peter AMJ, et al: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-5.
19. Klas C, Debatin K-M, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993;5:625-30.
20. Fujisawa K, Asahara H, Okamoto K, et al: Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-I tax transgenic mice. J Clin Invest; (in press).
21. Ogasawara J, Suda T, Nagata S: Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J Exp Med 1995;181:485-91.
22. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992;140:197-205.
23. Sato T, Irie S, Kitada S, Reed JC: FAP-1: Protein tyrosine phosphatase that associates with Fas. Science 1995;268:411-5.
24. Vaux DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993;90:786-9.
25. Yang Y, Mercep M, Ware CF, Ashwell JD: Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 1995;181:1673-82.